Alnylam Pharmaceuticals Inc. (ALNY) Social Stream
ALNYLAM PHARMACEUTICALS INC (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 17 | $275 | $108 | $200 | $195.71 | 2.19% |
| 2021-11-22 | 18 | $275 | $108 | $200 | $195.71 | 2.19% |
| 2021-12-29 | 19 | $275 | $108 | $202.5 | $195.71 | 3.47% |
| 2022-01-11 | 19 | $275 | $108 | $203.85 | $195.71 | 4.16% |
| 2022-01-18 | 19 | $275 | $108 | $203.3 | $195.71 | 3.88% |
| 2022-01-23 | 19 | $350 | $108 | $208.3 | $195.71 | 6.43% |
| 2022-01-28 | 18 | $350 | $108 | $208.2 | $195.71 | 6.38% |
| 2022-02-10 | 18 | $350 | $109 | $208.65 | $195.71 | 6.61% |
| 2022-02-14 | 16 | $350 | $103 | $212.052 | $195.71 | 8.35% |
| 2022-02-22 | 16 | $350 | $103 | $214.166 | $195.71 | 9.43% |
| 2022-03-10 | 16 | $350 | $103 | $214.631 | $195.71 | 9.67% |
| 2022-04-04 | 15 | $350 | $103 | $211.277 | $195.71 | 7.95% |
| 2022-04-12 | 15 | $400 | $103 | $214.055 | $195.71 | 9.37% |
| 2022-04-19 | 15 | $400 | $103 | $214.277 | $195.71 | 9.49% |
| 2022-04-25 | 15 | $400 | $103 | $214.277 | $195.71 | 9.49% |
| 2022-04-28 | 15 | $400 | $103 | $212.5 | $195.71 | 8.58% |
| 2022-05-02 | 15 | $430 | $96 | $212.444 | $195.71 | 8.55% |
| 2022-06-06 | 15 | $430 | $96 | $211.888 | $195.71 | 8.27% |
| 2022-06-15 | 16 | $430 | $96 | $211.888 | $195.71 | 8.27% |
| 2022-06-22 | 16 | $430 | $98 | $212.333 | $195.71 | 8.49% |
| 2022-07-22 | 18 | $430 | $97 | $210.157 | $195.71 | 7.38% |
| 2022-07-29 | 18 | $430 | $97 | $209.631 | $195.71 | 7.11% |
| 2022-08-03 | 18 | $430 | $97 | $207.842 | $195.71 | 6.2% |
| 2022-08-04 | 19 | $430 | $155 | $230.055 | $195.71 | 17.55% |
| 2022-08-13 | 19 | $430 | $155 | $233.117 | $195.71 | 19.11% |
| 2022-08-22 | 19 | $430 | $155 | $231.5 | $195.71 | 18.29% |
| 2022-09-17 | 19 | $430 | $155 | $236.5 | $195.71 | 20.84% |
| 2022-10-02 | 19 | $430 | $155 | $237.888 | $195.71 | 21.55% |
| 2022-10-03 | 19 | $430 | $155 | $240.058 | $195.71 | 22.66% |
| 2022-10-07 | 18 | $430 | $155 | $240.058 | $195.71 | 22.66% |
| 2022-10-12 | 18 | $430 | $155 | $239.941 | $195.71 | 22.6% |
| 2022-10-21 | 18 | $430 | $155 | $239.882 | $195.71 | 22.57% |
| 2022-10-24 | 18 | $430 | $142 | $238.882 | $195.71 | 22.06% |
| 2022-10-28 | 18 | $430 | $142 | $238.352 | $195.71 | 21.79% |
| 2022-10-31 | 20 | $430 | $142 | $239.684 | $195.71 | 22.47% |
| 2022-11-02 | 20 | $415 | $142 | $238.894 | $195.71 | 22.07% |
| 2022-12-07 | 20 | $415 | $145 | $239.052 | $195.71 | 22.15% |
| 2022-12-19 | 20 | $415 | $145 | $242.105 | $195.71 | 23.71% |
| 2022-12-23 | 20 | $415 | $145 | $244.263 | $195.71 | 24.81% |
| 2023-01-16 | 20 | $415 | $144 | $244.21 | $195.71 | 24.78% |
| 2023-01-23 | 20 | $415 | $143 | $244.157 | $195.71 | 24.75% |
| 2023-01-25 | 20 | $415 | $143 | $244.684 | $195.71 | 25.02% |
| 2023-01-27 | 20 | $415 | $143 | $244.736 | $195.71 | 25.05% |
| 2023-02-08 | 20 | $415 | $143 | $248.888 | $195.71 | 27.17% |
| 2023-02-21 | 21 | $415 | $143 | $251.789 | $195.71 | 28.65% |
| 2023-02-24 | 22 | $415 | $143 | $252.25 | $195.71 | 28.89% |
| 2023-02-26 | 22 | $415 | $136 | $250.75 | $195.71 | 28.12% |
| 2023-03-03 | 22 | $415 | $136 | $250.55 | $195.71 | 28.02% |
| 2023-03-31 | 22 | $415 | $136 | $250.19 | $195.71 | 27.84% |
| 2023-04-24 | 22 | $415 | $136 | $250.428 | $195.71 | 27.96% |
| 2023-05-05 | 23 | $415 | $136 | $249.045 | $195.71 | 27.25% |
| 2023-05-08 | 23 | $415 | $136 | $248.818 | $195.71 | 27.14% |
| 2023-06-06 | 23 | $415 | $136 | $249.954 | $195.71 | 27.72% |
| 2023-07-24 | 22 | $415 | $136 | $252.523 | $195.71 | 29.03% |
| 2023-07-26 | 22 | $405 | $140 | $252.238 | $195.71 | 28.88% |
| 2023-08-04 | 22 | $405 | $140 | $251.523 | $195.71 | 28.52% |
| 2023-08-07 | 22 | $405 | $141 | $250.571 | $195.71 | 28.03% |
| 2023-08-08 | 23 | $405 | $141 | $250.142 | $195.71 | 27.81% |
| 2023-09-18 | 23 | $405 | $141 | $252.65 | $195.71 | 29.09% |
| 2023-09-29 | 24 | $405 | $134 | $250.523 | $195.71 | 28.01% |
| 2023-10-10 | 24 | $405 | $125 | $241.409 | $195.71 | 23.35% |
| 2023-10-11 | 24 | $395 | $125 | $236.045 | $195.71 | 20.61% |
| 2023-10-16 | 24 | $395 | $125 | $234.545 | $195.71 | 19.84% |
| 2023-10-17 | 25 | $395 | $125 | $233.863 | $195.71 | 19.49% |
| 2023-11-03 | 25 | $395 | $125 | $230.217 | $195.71 | 17.63% |
| 2023-11-06 | 25 | $395 | $135 | $229.913 | $195.71 | 17.48% |
| 2023-11-15 | 25 | $395 | $135 | $229.434 | $195.71 | 17.23% |
| 2023-12-14 | 24 | $395 | $135 | $224.454 | $195.71 | 14.69% |
The Trend in the Analyst Price Target
Over the past 18 months, ALNY's average price target has gone up $12.12.
Over the past 48 weeks, ALNY's average upside potential has been 29.09%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-16 | 20 | 415 | 144 | 244.210 | 235.53 | 3.69% |
| 2023-06-06 | 22 | 415 | 136 | 252.523 | 192.96 | 30.87% |
| 2023-08-07 | 22 | 405 | 141 | 250.571 | 184.29 | 35.97% |
| 2023-10-11 | 24 | 395 | 125 | 236.045 | 167.82 | 40.65% |
| 2023-11-03 | 25 | 395 | 125 | 230.217 | 167.35 | 37.57% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.71 | 14 | 3 | 7 | 0 | 0 | 24 |
The Trend in the Broker Recommendations
ALNY's average broker recommendation rating worsened by 0.07 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALNY as an investment opportunity.
- ALNYLAM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -7659.6% of all US stocks.
- ALNYLAM PHARMACEUTICALS INC's number of analysts covering the stock is greater than 8054.38% of Pharmaceutical Products stocks.
- ALNYLAM PHARMACEUTICALS INC's average analyst price target is greater than 8004.85% of Pharmaceutical Products stocks.
- In terms of how ALNYLAM PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1883.02% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALNYLAM PHARMACEUTICALS INC are NKTR, IONS, and SRPT.
View All Top Stocks by Price Target
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!